FindMyKOL
Clinical trialNCT03925337CompletedInterventional

Computer Aided Detection of Polyps in the Colon

NCT03925337 is an interventional trial sponsored by Beth Israel Deaconess Medical Center. As of 18 Nov 2026, it is completed. It studies Colo-rectal Cancer and Polyp, Adenomatous. The registry lists an enrollment of 234 participants at 4 sites in 1 country. The registry lists a start date of 7 May 2019 and a primary completion date of 24 Nov 2020.

SponsorBeth Israel Deaconess Medical Center →Enrollment234Colo-rectal CancerPolyp, Adenomatous
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT03925337
FieldValue
Registry IDNCT03925337
StatusCompleted
Study typeInterventional trial
Lead sponsorBeth Israel Deaconess Medical Center
Enrollment234
Registered sites4
Countries1
ConditionsColo-rectal Cancer and Polyp, Adenomatous
Start7 May 2019
Primary completion24 Nov 2020
Study completion12 May 2021
Last update posted20 Jul 2021

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to examine the role of an automatic polyp detection software (henceforth referred to as the research software) as a support system during colonoscopy; a procedure during which a physician uses a colonoscope or scope, to look inside a patient's rectum and colon. The scope is a flexible tube with a camera-to see the lining of the colon. The research software is used to aid in the detection of polyps (abnormal tissue growths in the wall of the colon and adenomas (pre-cancerous growths) during colonoscopy. The research software used in this study was programmed by a company in Shanghai, which develops artificial intelligence software for computer aided diagnostics. The research software was developed using a large repository (database or databases) of polyp images where expert colonoscopists outlined polyps and suspicious lesions. The software was subsequently developed and validated using several databases of images and video to operate in near real-time or within minutes of photographing the tissue. It is intended to point out polyps and suspicious lesions on a separate screen that stands behind the primary monitor during colonoscopy. It is not expected to change the colonoscopy procedure in any way, and the physician will make the final determination on whether or not to biopsy or remove any lesion in the colon wall. The research software will not record any video data during the colonoscopy procedure. In the future, this software may help gastroenterologists detect precancerous areas and decrease the incidence of colon cancer in the United States.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Illinois, United States1 site
  • University of Chicago

    Chicago

Massachusetts, United States1 site
  • Beth Israel Deaconess Medical Center

    Boston

New York, United States1 site
  • Nyu Langone

    New York

Texas, United States1 site
  • Baylor College of Medicine

    Houston

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew York: 1 siteNY1Massachusetts: 1 siteMA1Rhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinois: 1 siteIL1IndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexas: 1 siteTX1FloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT03925337

Each answer restates registry values shown on this page.

What is NCT03925337?

NCT03925337 is an interventional trial sponsored by Beth Israel Deaconess Medical Center. It studies Colo-rectal Cancer and Polyp, Adenomatous.

Who leads NCT03925337?

The registry names Tyler M Berzin, MD (principal investigator, Beth Israel Deaconess Medical Center) as the overall official.

Where does NCT03925337 run?

The registry lists 4 sites in 1 country. Every site with a stated country is in one country: United States.

When did NCT03925337 end?

The registry lists a primary completion date of 24 Nov 2020 and a study completion date of 12 May 2021. The sponsor last updated the record on 20 Jul 2021.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.